Derivative spectrophotometric determination of rifampicin in the presence of Isonicotinyl Hydrazone in anti-tuberculosis fixed-dose combination (FDC) products

Indian Drugs

Volumn 43, Issue 2, 2006, Pages 106-111

  Mariappan, T T ^a   Kumar, V ^a   Vijaya, P ^a   Bhutani, H ^a   Singh, S ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Colorimetry; Derivative spectrophotometry; Isoniazid; Isonicotinyl hydrazone; Overestimation; Rifampicin

Indexed keywords

ETHAMBUTOL; HYDRAZONE DERIVATIVE; ISONIAZID; PHOSPHATE; PYRAZINAMIDE; RIFAMPICIN;

ACCURACY; COLORIMETRY; DISSOLUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PH; SPECTROPHOTOMETRY; TUBERCULOSIS;

EID: 77952126573     PISSN: 0019462X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Norval P.Y., Blomberg B., Kitler M.E., Dye C. and Spinaci S. Estimate of the global market for rifampicin-containing fixed-dose combination tablets. Int. J. Tuberc. Lung. Dis., 1999, 3, S292-S300.
2. Immanuel C., Gurumurthy P., Ramachandran G., Venkatesan P., Chandrasekaran V. and Prabhakar P. Bioavailability of rifampicin following concomitant administration of ethambutol or isoniazid or pyrazinamide or a combination of the three drugs. Indian J. Med. Res., 2003, 118, 109-114. (Pubitemid 38008123)
3. McIlleron H., Wash P., Burger A., Folb P. and Smith P. Widespread distribution of a single drug rifampicin formulation of inferior bioavailability in South Africa. Int. J. Tuberc. Lung Dis., 2002,6, 356-361. (Pubitemid 34263694)
4. Shishoo C.J., Shah S.A., Rathod I.S., Savale S.S. and Vora M.J. Impaired bioavailability of rifampicin in presence of isoniazid from fixed dose combination (FDC), formulation. Int. J. Pharm., 2001,228, 53-67. (Pubitemid 32905365)
5. Singh S. and Mohan B. A pilot stability study on antituberculosis four drug fixed dose combination products. Int. J. Tuberc. Lung Dis., 2003,7,298-303. (Pubitemid 36358773)
6. Bhutani H., Mariappan T.T. and Singh S. The physical and chemical stability of anti-tuberculosis fixed-dose combination (FDC) products under accelerated climatic conditions. Int. J. Tuberc. Lung Dis., 2004, 8, 1073- 1080. (Pubitemid 39201252)
7. Singh S., Mariappan T.T., Sharda N., Kumar S. and Chakraborti A.K. The reason for an increase in decomposition of rifampicin in the presence of isoniazid under acid conditions. Pharm. Pharmacol. Commun., 2000, 6, 405-410.
8. Singh S., Mariappan T.T., Sankar R., Sarda N. and Singh, B. A critical review of the probable reasons for the poor/variable bioavailability of rifampicin from anti- tubercular fixed-dose combination (FDC) products, and the likely solutions to the problem. Int. J. Pharm., 2001, 228, 5-17. (Pubitemid 32905361)
9. Bhutani H., Singh S., Jindal K.C. and Chakraborti A.K. Mechanistic explanation to the catalysis by pyrazinamide and ethambutol of reaction between rifampicin and isoniazid in anti-TB FDCs. J. Pharm. Biomed. Anal., 2005, In press.
10. MariappanT.T., Jindal K.C. and Singh S.Overestimation of rifampicin during colorimetric analysis of antituberculosis FDC products containing isoniazid due to formation of isonicotinyl hydrazone. J. Pharm. Biomed. Anal., 2004, 36, 905-908. (Pubitemid 39469435)
11. The United States Pharmacopeia, 27th rev., Asian Edition, United States Pharmacopeial Convention, Inc., Rockville, MD, 2004, pp. 1649-1655.
12. Jindal K.C., Chaudhary R.S., Singla A.K., Gangwal S.S. and Khanna S. Dissolution test method for rifampicin- isoniazid fixed dose formulations. J. Pharm. Biomed. Anal., 1994, 12-16.
13. Mariappan T.T., Singh B. and Singh S. Pharm. Pharmacol. Commun., 2000, 6, 345-349.
14. Mohan B., Sharda N. and Singh S. Evaluation of recently reported USP gradient method for anti-tuberculosis drugs in FDCs for its ability to resolve degradation products of rifampicin. J. Pharm. Biomed. Anal., 2003, 31, 607-612. (Pubitemid 36254906)
15. Erk N. Application of derivative-differential UV spectrometry and ratio derivative spectrophotometric determiantion of mephenoxalone and acetaminophen in combined tablet preparation. J. Pharm. Biomed. •Anal., 1999, 21,429-437. (Pubitemid 29502582)
16. Dine E., Kokdil G. and Onur F. Derivative ratio spectra-zero crossing spectrophotometry and LC applied to the quantitative determiantion of paracetamol, propyphenazone and caffeine in ternary mixtures. J. Pharm. Biomed. Anal., 2001, 26, 769-778. (Pubitemid 32971688)
17. Morelli B. Derivative spectrophotometry in the analysis of mixtures of cefotaxime sodium and cefadroxil monohydrate. J. Pharm. Biomed. Anal., 2003,32,257-267. (Pubitemid 36588726)